Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06307340 · ClinicalTrials.gov registry record · NA
Adaption of the STAIR-NT Trauma Intervention for Polysubstance Populations
A NA study of Posttraumatic Stress Disorder and Polysubstance Abuse, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 3
- Study locations
NCT06307340 is a NA study of Posttraumatic Stress Disorder and Polysubstance Abuse that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 76 participants, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (32% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT06307340, a NA study of Posttraumatic Stress Disorder and Polysubstance Abuse, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 3
- Study locations
Study Summary
During this 36-month R34 trial, eight study phases are proposed to adapt an evidence-based post traumatic stress disorder (PTSD) intervention (STAIR-NT) and layer it into a methadone maintenance treatment (MMT) program (START Treatment and Recovery centers) in New York City for use among individuals engaged in stimulant-opioid polysubstance use. The study aims to adapt STAIR-NT to a massed treatment schedule. Once an adapted protocol is complete, it will be tested for feasibility, acceptability, and short-term polysubstance and PTSD symptomology outcomes in a pilot randomized control trial (RCT) of 80 participants. Participants who screen eligible and consent will be randomized 1:1 to the adapted STAIR-NT intervention or treatment as usual (TAU) using randomization blocks of two and two and four via a computer-generated randomization sequence. Participants assigned to the intervention will receive the adapted massed delivery of STAIR-NT by trained counselors.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Skills Training in Affective and Interpersonal Regulation with Narrative Therapy (STAIR-NT)
Study Locations (3)
New York
- START Treatment and Recovery Centers - Brooklyn
- NYU Langone Health - New York
Florida
- Florida State University - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2024-10-14 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06307340
The ClinicalTrials.gov registry entry for NCT06307340 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (32% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT06307340 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Florida.
Frequently Asked Questions
What is clinical trial NCT06307340 about?
NCT06307340 is a clinical study titled "Adaption of the STAIR-NT Trauma Intervention for Polysubstance Populations". During this 36-month R34 trial, eight study phases are proposed to adapt an evidence-based post traumatic stress disorder (PTSD) intervention (STAIR-NT) and layer it into a methadone maintenance treatment (MMT) program (START Treatment and Recovery centers) in New York City for use among individuals...
What is the current status of trial NCT06307340?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2024-10-14. Estimated completion is 2026-09-30.
What conditions does trial NCT06307340 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder, Polysubstance Abuse.
What interventions are being tested in trial NCT06307340?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Skills Training in Affective and Interpersonal Regulation with Narrative Therapy (STAIR-NT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06307340?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06307340 being conducted?
This trial has 3 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Impact of Cognitive Behavioral Therapy on PTSD-CVD Link
RECRUITING · NA
-
A Mechanistic Trial of the Neurobiology of Extinction Learning and Intraparietal Sulcus Stimulation
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.